Nano-X Imaging increased first-quarter revenue and placed its Nanox.ARC at a RadNet site, but slow activations, withdrawn guidance and a going-concern warning leave the medical imaging company facing a difficult commercial test.
Gut diagnostics need proof, not buzz. Gemelli Biotech’s DDW 2026 visibility could test whether IBS and SIBO care is ready for precision tools.
Vista AI, a U.S.-based medical imaging software company specializing in AI-powered MRI automation, has raised $29.5 million in Series B financing to accelerate its product roadmap and scale adoption across U.S. hospitals and imaging centers. The funding round, announced on January 14, 2026, includes strategic investments from leading health systems such as Cedars-Sinai Health System,